Ex vivo gene therapy: Transplantation of neurotrophic factor-secreting cells for cerebral ischemia

Takao Yasuhara, Cesario V. Borlongan, Isao Date

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Expressions of various neurotrophic factors or their receptors fluctuate after stroke, which in part prompted investigations into the efficacy of neurotrophic factors as treatment modality for stroke. The methods to deliver neurotrophic factors into the brain can be categorized into: 1) the surgical route of administration, such as intracerebral, intraventricular, intra-arterial, or intravenous systemic administration and 2) the manipulation of the therapeutic molecules via ex vivo or in vivo techniques. With ex vivo method, genetically engineered cells, including the use of autologous cells, have been explored. In this review, the potent therapeutic applications of neurotrophic factors in stroke are described, with emphasis on ex vivo methods, especially transplantation of encapsulated stem cells modified with adenovirus. Neurotrophic factor delivery, combined with ex vivo method, poses as novel treatment for stroke, although additional safety and efficacy studies remain to be examined.

Original languageEnglish
Pages (from-to)760-775
Number of pages16
JournalFrontiers in Bioscience
Volume11
Issue number1 P.447-888
DOIs
Publication statusPublished - 2006

Fingerprint

Gene therapy
Nerve Growth Factors
Brain Ischemia
Genetic Therapy
Transplantation
Stroke
Stem Cell Transplantation
Therapeutics
Stem cells
Adenoviridae
Intravenous Administration
Brain
Safety
Molecules

Keywords

  • BDNF
  • Brain
  • Cytokine
  • Encapsulation
  • ex vivo
  • GDNF
  • Gene therapy
  • Nervous system
  • Neurotrophic factor
  • Review
  • Stem cell
  • Stroke
  • Therapeutics
  • Treatment
  • VEGF

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

Ex vivo gene therapy : Transplantation of neurotrophic factor-secreting cells for cerebral ischemia. / Yasuhara, Takao; Borlongan, Cesario V.; Date, Isao.

In: Frontiers in Bioscience, Vol. 11, No. 1 P.447-888, 2006, p. 760-775.

Research output: Contribution to journalArticle

@article{77b54cde1bec4db385be0b132b1019ff,
title = "Ex vivo gene therapy: Transplantation of neurotrophic factor-secreting cells for cerebral ischemia",
abstract = "Expressions of various neurotrophic factors or their receptors fluctuate after stroke, which in part prompted investigations into the efficacy of neurotrophic factors as treatment modality for stroke. The methods to deliver neurotrophic factors into the brain can be categorized into: 1) the surgical route of administration, such as intracerebral, intraventricular, intra-arterial, or intravenous systemic administration and 2) the manipulation of the therapeutic molecules via ex vivo or in vivo techniques. With ex vivo method, genetically engineered cells, including the use of autologous cells, have been explored. In this review, the potent therapeutic applications of neurotrophic factors in stroke are described, with emphasis on ex vivo methods, especially transplantation of encapsulated stem cells modified with adenovirus. Neurotrophic factor delivery, combined with ex vivo method, poses as novel treatment for stroke, although additional safety and efficacy studies remain to be examined.",
keywords = "BDNF, Brain, Cytokine, Encapsulation, ex vivo, GDNF, Gene therapy, Nervous system, Neurotrophic factor, Review, Stem cell, Stroke, Therapeutics, Treatment, VEGF",
author = "Takao Yasuhara and Borlongan, {Cesario V.} and Isao Date",
year = "2006",
doi = "10.2741/1834",
language = "English",
volume = "11",
pages = "760--775",
journal = "Frontiers in Bioscience - Landmark",
issn = "1093-9946",
publisher = "Frontiers in Bioscience",
number = "1 P.447-888",

}

TY - JOUR

T1 - Ex vivo gene therapy

T2 - Transplantation of neurotrophic factor-secreting cells for cerebral ischemia

AU - Yasuhara, Takao

AU - Borlongan, Cesario V.

AU - Date, Isao

PY - 2006

Y1 - 2006

N2 - Expressions of various neurotrophic factors or their receptors fluctuate after stroke, which in part prompted investigations into the efficacy of neurotrophic factors as treatment modality for stroke. The methods to deliver neurotrophic factors into the brain can be categorized into: 1) the surgical route of administration, such as intracerebral, intraventricular, intra-arterial, or intravenous systemic administration and 2) the manipulation of the therapeutic molecules via ex vivo or in vivo techniques. With ex vivo method, genetically engineered cells, including the use of autologous cells, have been explored. In this review, the potent therapeutic applications of neurotrophic factors in stroke are described, with emphasis on ex vivo methods, especially transplantation of encapsulated stem cells modified with adenovirus. Neurotrophic factor delivery, combined with ex vivo method, poses as novel treatment for stroke, although additional safety and efficacy studies remain to be examined.

AB - Expressions of various neurotrophic factors or their receptors fluctuate after stroke, which in part prompted investigations into the efficacy of neurotrophic factors as treatment modality for stroke. The methods to deliver neurotrophic factors into the brain can be categorized into: 1) the surgical route of administration, such as intracerebral, intraventricular, intra-arterial, or intravenous systemic administration and 2) the manipulation of the therapeutic molecules via ex vivo or in vivo techniques. With ex vivo method, genetically engineered cells, including the use of autologous cells, have been explored. In this review, the potent therapeutic applications of neurotrophic factors in stroke are described, with emphasis on ex vivo methods, especially transplantation of encapsulated stem cells modified with adenovirus. Neurotrophic factor delivery, combined with ex vivo method, poses as novel treatment for stroke, although additional safety and efficacy studies remain to be examined.

KW - BDNF

KW - Brain

KW - Cytokine

KW - Encapsulation

KW - ex vivo

KW - GDNF

KW - Gene therapy

KW - Nervous system

KW - Neurotrophic factor

KW - Review

KW - Stem cell

KW - Stroke

KW - Therapeutics

KW - Treatment

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=32944457053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32944457053&partnerID=8YFLogxK

U2 - 10.2741/1834

DO - 10.2741/1834

M3 - Article

C2 - 16146768

AN - SCOPUS:32944457053

VL - 11

SP - 760

EP - 775

JO - Frontiers in Bioscience - Landmark

JF - Frontiers in Bioscience - Landmark

SN - 1093-9946

IS - 1 P.447-888

ER -